Spyre Therapeutics Inc (SYRE)

Operating Cash Flow Growth

-35.52%

TTM · Period ending:

SYRE logo

SYRE Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-35.52%
SYRE TTM Cash from Operations YoY % (-49.72% → -35.52%)
High-resolution chart · PNG

SYRE operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Spyre Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-35.5222%
-9.2828%
-7.523%
-7.0256%
1.4359%
-53.2802%
-57.5518%
-73.8192%
-131.7893%
-54.9577%
-24.6631%
-7.0652%
18.8921%
-18.3063%
-49.1995%
-57.5649%
-59.6515%
17.8805%
29.1112%
31.1688%
30.1478%
-2.8388%
-15.3489%
-32.4022%
-55.7859%
-76.5073%
-104.0568%
-83.3668%
-61.079%
-52.2831%
-30.7861%
-33.6364%
-37.6864%
-31.2857%
-30.6529%
-50.7834%
-62.8016%
-62.4409%
-71.5535%
-16.7175%
-19.3342%
-47.3045%
-49.7205%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.